Everybody Hurts: VC Investment in the Pain Industry
April 14, 2014
Over the last five years, VC investors have completed 79 deals involving companies that provide solutions helping people relieve, get rid of or manage pain, according to the PitchBook Platform. About one in five of those deals reached or eclipsed $25 million in size. These companies' solutions and technologies help those suffering from pain due to surgery, cancer and other diseases, serious injury and more. Among the companies is Spinifex Pharmaceuticals, which just last week raised $45 million in funding led by Novo A/S. Some other noteworthy companies in the space that have landed VC coin include Nevro ($58.6 million in 2011), Flexion Therapeutics ($55 million in 2012) and Xanodyne Pharmaceuticals ($50 million in 2009).
In total, VC investors have poured nearly $1 billion into these companies during the timeframe. The two subsectors within the pain space that have attracted the largest portions of the deal flow have been therapeutic devices (36%) and pharmaceuticals (18%).